Publications

Mally A, Zepnik H, Wanek P, Eder E, Dingley K, Ihmels H., et al. 2004. Ochratoxin A: Lack of formation of covalent DNA adducts. Chem Res Toxicol 17(2):234–242; doi: 10.1021/tx034188m. PMID: 14967011.

Rogers JM, Brannen KC, Barbee BD, Zucker RM, Degitz SJ. 2004. Maternal methanol exposure during gastrulation causes holoprosencephaly, facial dysgenesis and cervical vertebral malformations in C57BL/6J mice. Birth Defects Res B 71(2):80-88; doi: 10.1002/bdrb.20003.

Degitz SJ, Zucker RM, Kawanishi CY, Massenburg GS, Rogers JM. 2004. Pathogenesis of methanol-induced craniofacial defects in C57BL/6J mice. Birth Defects Res A 70(4):172–178; doi: 10.1002/bdra.20010. PMID: 15108243.

Clewell HJ, Gentry PR, Covington TR, Sarangapani R, Teeguarden JG. 2004. Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Toxicol Sci 79(2):381–93; doi: 10.1093/toxsci/kfh109.

Lau C, JL Butenhoff, JM Rogers. 2004. The developmental toxicity of perfluoroalkyl acids and their derivatives. Toxicol Appl Pharmacol 198(2):231-241; doi: 10.1016/j.taap.2003.11.031.

Kim DJ, Akiyama TE, Harman FS, Burns AM, Shan W, Ward JM, Kennett MJ, Gonzalez FJ, Peters JM. 2004. Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis. J Biol Chem 279(22):23719-23727; doi: 10.1074/jbc.M312063200. PMID: 15033975.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. 2004. Perfluorooctane sulfonate (PFOS) alters lung development in the neonatal rat. Birth Defects Res A 70(5)264, Abstract 42; doi: 10.1002/bdra.20026.

Hardick J, Gaydos CA, Wagner M, Hardick A, Wood BJ, Miller M. High prevalence of trichomonas vaginalis among women who use drugs in New York City. National STD Prevention Conference, Philadelphia, PA, 2004.

Degitz SJ, Rogers JM, Zucker RM, Hunter ES III. 2004. Developmental toxicity of methanol: Pathogenesis in CD-1 and C57BL/6J mice exposed in whole embryo culture. Birth Defects Res A 70(4):179–184; doi: 10.1002/bdra.20009. PMID: 15108244.

Buffler PA, Kelsh MA, Chapman P, Wood S, Lau E, Golembesky A, et al. 2004. Primary brain tumor mortality at a petroleum exploration and extraction research facility. J Occup Environ Med 46(3):257–270; doi: 10.1097/01.jom.0000116816.09199.6d. PMID: 15091289.

Staskal DF, Diliberto JJ, DeVito MJ, Birnbaum LS. Disposition of 2,2’,4,4’-tetrabromodiphenylether (BDE 47) in female mice. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Grasty RC, Roberts N, Grey BE, Lau C, Rogers JM. Effects of prenatal exposure to perfluorooctane sulfonate on the developing lung in the rat. Society for Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Urban JD, Gay EA, Mailman RB. Decreased neurological side-effects with aripiprazole: A result of functional selectivity of the D2 receptor? Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Tice RR, Choksi NY, Allen DG, Haseman JH, Hill R, Lewis M, et al. Estimation of the underprediction rates for the in vivo rabbit dermal corrosion assay. Poster presented at Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Choksi NY, Haseman JH, Allen DG, Tice RR, Stokes WS. Estimation of the underprediction rates for the in vivo rabbit dermal irritation assay. Poster presented at Society of Toxicology 43rd Annual Meeting, Baltimore, MD, March 2004.

Jahnke GD, Choksi NY, Moore JA, Shelby MD. 2004. Thyroid toxicants: Assessing reproductive health effects. Environ Health Perspect 112(3):363–368; doi: 10.1289/ehp.6637. PMID: 14998754.

Kelsh MA, Bracken TD, Sahl JD, Shum M, Ebi KL. 2003. Occupational magnetic field exposures of garment workers: Results of personal and survey measurements. Bioelectromagnetics 24(5):316–326; doi: 10.1002/bem.10112. PMID: 12820289.

Thompson CM, Wojno H, Greiner E, May EL, Rice KC, Selley DE. 2004. Activation of G-proteins by morphine and codeine congeners: Insights to the relevance of O- and N-demethylated metabolites at μ- and δ-opioid receptors. J Pharmacol Exper Therapeut 308(2):547–554; doi: 10.1124/jpet.103.058602. PMID: 14600248.

Birnbaum LS, Staskal DF. 2004. Brominated flame retardants: Cause for concern? Environ Health Perspect 112(1):9-17; doi: 10.1289/ehp.6559. PMID: 14698924.

Grasty RC, Grey BE, Lau CS, Rogers JM. 2003. Prenatal window of susceptibility to perfluorooctane sulfonate-induced neonatal mortality in the Sprague-Dawley rat. Birth Defects Res B 68(6):465–471; doi: 10.1002/bdrb.10046. PMID: 14745980.